Tempus AI Newsroom

Buy Rating Affirmed for Personalis Amidst Rapid Commercialization and Strong Tempus AI Partnership

TipRanksAug 16 09:57 ET

Tempus AI Analyst Ratings

BenzingaAug 12 05:49 ET

Analysts Conflicted on These NA Names: Astera Labs, Inc. (ALAB) and Tempus AI, Inc. Class A (TEM)

TipRanksAug 7 08:02 ET

Tempus AI Price Target Maintained With a $47.00/Share by Needham

Dow JonesAug 7 05:40 ET

Tempus AI Analyst Ratings

BenzingaAug 7 05:30 ET

TD Cowen Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsAug 7 01:32 ET

Buy Rating Justified for Tempus AI, Inc. Class A on Strong Q1 Performance and Upbeat 2024 Guidance

TipRanksAug 7 01:02 ET

Stifel Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $45

Moomoo NewsAug 5 07:33 ET

Stifel Nicolaus Reaffirms Their Buy Rating on Tempus AI, Inc. Class A (TEM)

TipRanksAug 5 07:29 ET

TD Cowen Maintains Tempus AI(TEM.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsAug 1 06:33 ET

Maintained Buy Rating for Tempus AI, Inc. Class A Amid Inconsequential Financial Adjustments

TipRanksAug 1 06:28 ET

Needham Initiates Tempus AI at Buy With $47 Price Target

MT NewswiresJul 9 06:52 ET

Buy Rating Affirmed for Tempus AI, Inc. on Strong Growth and AI-Driven Healthcare Innovation

TipRanksJul 9 06:37 ET

Tempus AI Analyst Ratings

BenzingaJul 9 05:40 ET